Heron Therapeutics
HRTX
#8228
Rank
A$0.36 B
Marketcap
A$2.00
Share price
-1.48%
Change (1 day)
-26.42%
Change (1 year)

Heron Therapeutics (HRTX) - Cash on Hand

Cash on Hand as of September 2025 : A$83.44 Million

According to Heron Therapeutics's latest financial reports the company has A$83.44 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Heron Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$95.31 M-19.24%
2023-12-31A$0.11 B-5.35%
2022-12-31A$0.12 B-42.63%
2021-12-31A$0.21 B-19.84%
2020-12-31A$0.27 B-51.44%
2019-12-31A$0.55 B18.36%
2018-12-31A$0.47 B113.68%
2017-12-31A$0.22 B211.23%
2016-12-31A$70.94 M-60.6%
2015-12-31A$0.18 B102.76%
2014-12-31A$88.8 M9.58%
2013-12-31A$81.04 M57.4%
2012-12-31A$51.48 M193.72%
2011-12-31A$17.52 M744.3%
2010-12-31A$2.07 M-75.44%
2009-12-31A$8.45 M-43.41%
2008-12-31A$14.93 M-62.76%
2007-12-31A$40.1 M103.67%
2006-12-31A$19.69 M148.02%
2005-12-31A$7.93 M-54.81%
2004-12-31A$17.56 M37.7%
2003-12-31A$12.75 M-49.09%
2002-12-31A$25.06 M-34.38%
2001-12-31A$38.19 M-5.17%
2000-12-31A$40.28 M614.4%
1999-12-31A$5.63 M-15.79%
1998-12-31A$6.69 M-49.86%
1997-12-31A$13.35 M96.45%
1996-12-31A$6.79 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Alkermes
ALKS
A$1.67 B 1,902.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
A$0.37 B 343.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$0.40 B 386.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.01 B 1,119.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
A$49.21 M-41.02%๐Ÿ‡บ๐Ÿ‡ธ USA